Evaluation of Cardiovascular Risk Factors Prevalence and Efficacy of Their Correction in Physicians. Estimation of Physicians’ Expertise in Up-to-Date Clinical Guidelines. Results of the “Physician’s Health and Education” Study

Drozdova, L. Yu.; Martsevich, S. Yu.; Воронина, В. П.

doi:10.20996/1819-6446-2011-7-2-137-144

Cited by 10 publications

(4 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Clinical guidelines in Russia are very similar to Europe as they are translated and adapted from the guidelines of the European Society of Cardiology. The state of knowledge concerning the efficacy of statins in the Russian medical profession is underlined by a recent study of physician health in Russia which found that physicians themselves do not take statins even if they are at very high risk of cardiovascular disease (only 13 % of physicians who needed statin treatment actually took it) [ 37 ]. If physicians themselves do not think it is necessary to take statins themselves this decreases the chance of systematic prescription of statins to patients.…”

Section: Discussionmentioning

confidence: 99%

Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia

Cybulsky

Cook

Kontsevaya

et al. 2016

BMC Cardiovasc Disord

View full text Add to dashboard Cite

BackgroundCardiovascular disease (CVD) is the leading cause of death in Russia. Hypertension and hyperlipidemia are important risk factors for CVD that are modifiable by pharmacological treatment and life-style changes. We aimed to characterize the extent of the problem in a typical Russian city by examining the prevalence, treatment and control rates of hypertension and hyperlipidemia and investigating whether the specific pharmacological regimes used were comparable with guidelines from a country with much lower CVD rates.MethodsThe Izhevsk Family Study II included a cross-sectional survey of a population sample of 1068 men, aged 25–60 years conducted in Izhevsk, Russia (2008–2009). Blood pressure and total cholesterol were measured and self-reported medication use was recorded by a clinician. We compared drug treatments with the Russian and Canadian treatment guidelines for hypertension and hyperlipidemia.ResultsThe prevalence of hypertension was 61 % (age-standardised prevalence 51 %), with 66 % of those with hypertension aware of their diagnosis and 50 % of those aware taking treatment. 17 % of those taking treatment achieved blood pressure control. The majority (59 %) of those taking treatment were not doing so regularly. Prevalence of hyperlipidemia was 45 % (age-standardised prevalence 40 %), however less than 2 % of those with hyperlipidemia were taking any treatment. Types of lipid-lowering and anti-hypertensive medications prescribed were broadly in line with Russian and Canadian guidelines.ConclusionThe prevalence of hypertension and hyperlipidemia is high in Izhevsk while the proportion of those treated and attaining treatment targets is very low. Prescribed medications were concurrent with those in Canada, but adherence is a major issue.

show abstract

Section: Discussionmentioning

confidence: 99%

Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia

Cybulsky

Cook

Kontsevaya

et al. 2016

BMC Cardiovasc Disord

View full text Add to dashboard Cite

show abstract

“…A further potentially strong influence on patient adherence and persistence is the personal beliefs of health professionals and general population attitudes. ‘Therapeutic inertia’ among physicians has been reported to contribute to poor management of cardiovascular risk factors in Russia and the USA [24, 25]. The fact that 31% of the post-MI subgroup of DIAPAsOn were classified as current smokers may be indicative of attitudinal factors that operate to the general detriment of adherence.…”

Section: Discussionmentioning

confidence: 99%

Use of digital technology tools to characterize patient adherence to prescription-grade omega-3 polyunsaturated fatty acid therapy: Primary results of the DIAPAsOn prospective observational study

Arutyunov

Ageev

et al. 2022

Preprint

View full text Add to dashboard Cite

Background, objectives and methods: DIAPAsOn was a 6-month prospective observational multicenter study in the Russian Federation that examined adherence to a preparation of highly purified omega-3 polyunsaturated fatty acids (OMACOR) in adult patients with a history of recent myocardial infarction or endogenous hypertriglyceridemia. A full description of the study aims and methods has appeared in JMIR Res Protoc. A feature of DIAPAsOn was the use of a bespoke electronic patient engagement and data collection system. Results: The net average reduction from baseline in both total and low-density lipoprotein cholesterol was approximately 1 mmol/L and the net average increment in high-density lipoprotein cholesterol was 0.2+/-0.53 mmol/L. Mean triglyceride levels declined by ~1.3 mmol/, from an initial level of 2.99+/-1.29 mmol/L to 1.67+/- 0.67 mmol/L. The percentage of patients with triglyceride <1.7 mmol/L rose from 13.1% at baseline to 54% at study-end. Digital reporting of adherence was registered by 8.3% of patients (n=180) and average scores indicted poor adherence. However, clinic-based enquiry suggested high levels of adherence. Data on health-related quality of life accrued from digitally-engaged patients identified improvements among patients reporting high adherence to study treatment, but patient numbers were small. Conclusions: The lipid and lipoprotein findings indicate that OMACOR had nominally favorable effects on the blood lipid profile. Less than 10% of patients enrolled in DIAPAsOn used the bespoke digital platform piloted in the study and the level of self-reported adherence to medication by those patients was also low. Reasons for this low uptake and adherence are unclear. Better adherence was recorded by clinical report.

show abstract

“…По данным Л.Ю. Дроздовой и соавт., которые были опубликованы в 2011 г., 59% врачей не посчитали нужным немедленно назначить лекарственную терапию пациенту с АГ и высоким риском ССО [8]. Анализ ответов на вопросы первого раздела основной части анкеты позволяет прийти к заключению о том, что врачи не придают должного значения стратификации риска ССО у пациентов с АГ и недооценивают значение этого этапа диагностики для правильного выбора антигипертензивной терапии.…”

Section: Discussionunclassified

Doctors’ Adherence to the Guidelines on the Diagnostics and Treatment of Arterial Hypertension

Перепеч

Shurygina

Tregubov

2019

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

Aim. Examination of knowledge of the basic provisions of clinical guidelines for the management of patients with arterial hypertension and finding out the readiness of doctors for the practical application of updated recommendationsMaterial and methods. Anonymous questionnaires of 306 doctors served as material for the study. The questionnaire consisted of two parts. The introductory part included questions that allow to find out the specialty, work experience, gender, age, and whether the respondent has cardiovascular risk factors. The main part of the questionnaire included 16 questions regarding provisions of the guidelines on the diagnosis and treatment of arterial hypertension in force at the time of the survey (2017/2018 academic year). Statistical processing of the results was carried out using the Microsoft Excel 2010 software package. Differences were regarded as significant at p<0.05.Results. The findings suggest that both therapists and cardiologists do not give due importance to the risk stratification of cardiovascular complications in patients with arterial hypertension and are not sufficiently aware of the possibilities and limitations of the use of combinations of antihypertensive drugs. Therapists worse than cardiologists know the main points of the clinical guidelines for the management of patients with arterial hypertension (target blood pressure levels during treatment [64.6% vs 87.7%, p<0.001], indications for combination antihypertensive therapy starting, the possibility of fixed dose combinations using [52.3% vs 83.9%, p<0.001]). A significant part of physicians (both cardiologists and therapists) adequately assess the antihypertensive treatment effectiveness, not enough frequent achievement of the target blood pressure level in their patients and is willing to provide more strict control of blood pressure.Conclusion. The results of the survey indicate the need of the active education of doctors in the management of patients with arterial hypertension. The most attention should be paid to the training of therapists and general practitioners on the cardiovascular complications risk stratification, the using of the antihypertensive drugs combinations use and methods to increase patient adherence to antihypertensive therapy.

show abstract

Evaluation of Cardiovascular Risk Factors Prevalence and Efficacy of Their Correction in Physicians. Estimation of Physicians’ Expertise in Up-to-Date Clinical Guidelines. Results of the “Physician’s Health and Education” Study

Cited by 10 publications

References 9 publications

Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia

Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia

Use of digital technology tools to characterize patient adherence to prescription-grade omega-3 polyunsaturated fatty acid therapy: Primary results of the DIAPAsOn prospective observational study

Doctors’ Adherence to the Guidelines on the Diagnostics and Treatment of Arterial Hypertension

Contact Info

Product

Resources

About